Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (MERIT) Trial-24-week Outcomes of Uveitic Macular Edema Retreatment.
Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee; Gonzales J, Acharya NR, Sugar EA, Burke AE, Vitale AT, Gupta V, Dunn JP, Lightman SL, Thorne JE, Kim RY, Yeh S, Altaweel MM, Kempen JH, Holbrook JT, Jabs DA. Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee, et al. Among authors: dunn jp. Ophthalmology. 2024 Nov 27:S0161-6420(24)00746-2. doi: 10.1016/j.ophtha.2024.11.021. Online ahead of print. Ophthalmology. 2024. PMID: 39612949
Outcomes of Postcataract Surgery Endophthalmitis Managed Without Microbial Cultures.
Samuelson AG, Patel SN, Kommareddy K, Momenaei B, Yu-Chuan Kang E, Chaudhary V, Hsu J, Dunn JP, Vander JF, Garg SJ. Samuelson AG, et al. Among authors: dunn jp. Ophthalmol Retina. 2024 Jul 20:S2468-6530(24)00338-5. doi: 10.1016/j.oret.2024.07.015. Online ahead of print. Ophthalmol Retina. 2024. PMID: 39038541
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity.
Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A, Sands SA, Schwab RJ, Dunn JP, Chakladar S, Bunck MC, Bednarik J; SURMOUNT-OSA Investigators. Malhotra A, et al. Among authors: dunn jp. N Engl J Med. 2024 Oct 3;391(13):1193-1205. doi: 10.1056/NEJMoa2404881. Epub 2024 Jun 21. N Engl J Med. 2024. PMID: 38912654 Clinical Trial.
Weight-Reduction Preferences Among OBSERVE Study Participants With Obesity or Overweight: Opportunities for Shared Decision-Making.
Gudzune KA, Kaplan LM, Kahan S, Kumar RB, Dunn JP, Ahmad NN, Poon JL, Sims TJ, Mackie DS, Jauregui AK, Balkaran BL, Kan H, Ard J; OBSERVE study. Gudzune KA, et al. Among authors: dunn jp. Endocr Pract. 2024 Oct;30(10):917-926. doi: 10.1016/j.eprac.2024.06.009. Epub 2024 Jun 18. Endocr Pract. 2024. PMID: 38901731 Free article.
Diagnostic and Therapeutic Challenges.
Shieh D, Paul SK, Beckman M, Kurup SK, Dunn JP. Shieh D, et al. Among authors: dunn jp. Retina. 2024 Oct 1;44(10):1845-1850. doi: 10.1097/IAE.0000000000004123. Retina. 2024. PMID: 38574373 No abstract available.
Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial.
Malhotra A, Bednarik J, Chakladar S, Dunn JP, Weaver T, Grunstein R, Fietze I, Redline S, Azarbarzin A, Sands SA, Schwab RJ, Bunck MC. Malhotra A, et al. Among authors: dunn jp. Contemp Clin Trials. 2024 Jun;141:107516. doi: 10.1016/j.cct.2024.107516. Epub 2024 Mar 26. Contemp Clin Trials. 2024. PMID: 38547961 Free article. Clinical Trial.
274 results